National Cancer Institute
National Cancer Institute U.S. National Institutes of Health
Engaging the cancer community to advance NCI-supported clinical trials. The effort to transform the NCI's Clinical Trials Enterprise starts here. Learn more.


NCI Recognizes Clinical Investigators with 2013 Cancer Clinical Investigator Team Leadership Award (CCITLA) - 09/30/2013

The NCI has recognized 11 outstanding clinical investigators with a two-year award to acknowledge and support leaders in clinical cancer research programs at NCI Designated Cancer Centers. This fifth cohort of investigators joins a group of 46 other outstanding clinical investigators who received this prestigious award in 2009 – 2012

An updated request for applications from NCI Designated Cancer Centers is anticipated by early 2014.

6 New Funding Opportunities Announced for NCI's National Clinical Trials Network (NCTN) - 7/27/2012

The goal of the NCTN is to develop and conduct state-of-the-art cancer treatment and advanced imaging clinical trials, especially large, definitive multi-institutional trials evaluating new cancer therapies and related clinical approaches for both adult and pediatric patients. Comprehensive discussions with all major clinical trial stakeholders and NCI Advisory Boards over a 2-year period led to the development of the new Network structure described in the Funding Opportunity Announcements (FOAs). The NCTN consists of 6 components, each with its own FOA. These components are: Network Group Operations Centers; Network Group Statistics and Data Management Centers; Network Group Integrated Translation Science Support Centers; Lead Academic Participating Site Centers; Network Radiotherapy and Imaging Core Services Centers; and a Canadian Collaborating Clinical Trials Network.

More Highlights

CTWG Initiatives

The 22 Clinical Trials Working Group (CTWG) initiatives can be broadly categorized as addressing coordination, scientific prioritization, standardization, operational efficiency, and enterprise-wide concerns.

Scientific Steering Committees

A central element of NCI's efforts to transform the clinical trials enterprise is the organization of Scientific Steering Committees composed of outside cancer experts and NCI senior investigators.